组胺
体外毒理学
百日咳毒素
药理学
体外
戒毒(替代医学)
敏化
生物
生物化学
免疫学
医学
G蛋白
病理
受体
替代医学
作者
Hokyung Oh,Byoung Guk Kim,Kyung Tak Nam,Seung Hwa Hong,Do-Hee Ahn,Gi Sub Choi,Hyungjin Kim,Jin Tae Hong,Byung Yoon Ahn
出处
期刊:Vaccine
[Elsevier BV]
日期:2013-06-01
卷期号:31 (29): 2988-2993
被引量:14
标识
DOI:10.1016/j.vaccine.2013.04.060
摘要
Pertussis toxin (PTx) is an essential component of the acellular pertussis (aP) vaccine. However, because PTx in its native form is considered too toxic for human vaccine use, it must be inactivated into a stable, nontoxic form by treatment with chemical detoxifying agents or by genetic modification. Therefore, testing for the residual PTx in the aP vaccine is a major quality control step for vaccine manufacturers and regulatory authorities. The histamine sensitization test is currently the standard safety test method for all aP vaccines, regardless of the vaccine formula or the detoxification process, except for those with genetically modified PTx. However, test result variability and ethical concerns regarding animal use necessitate an alternative method. In vitro assays based on the biochemical properties of PTx have been considered as potential alternatives to the histamine sensitization test. In this study, the suitability of assays based on the ADP-ribosyltransferase and carbohydrate binding activities of PTx was assessed for PTx after treatment with formaldehyde, glutaraldehyde or both denaturants in sequence. The results indicated a distinctive pattern of the biochemical activities depending on the detoxification methods and storage conditions. These results suggest that although a more careful study is needed, these in vitro biochemical assays can be considered potential alternatives to the histamine sensitization test, as they might provide more specific safety information of aP vaccines.
科研通智能强力驱动
Strongly Powered by AbleSci AI